The University of Chicago Header Logo

Connection

Chang Sun to Crystallization

Back to Details
This is a "connection" page, showing publications Chang Sun has written about Crystallization.
Chang Sun
Connection Strength
8.261
Crystallization
  1. Decreased Crystal Plasticity by Solvation - the Case of Levofloxacin Acesulfame. Mol Pharm. 2025 Mar 03; 22(3):1598-1604.
    View in: PubMed
    Score: 0.921
  2. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression. J Pharm Sci. 2018 04; 107(4):968-974.
    View in: PubMed
    Score: 0.561
  3. Origin of two modes of non-isothermal crystallization of glasses produced by milling. Pharm Res. 2012 Apr; 29(4):1020-32.
    View in: PubMed
    Score: 0.370
  4. On the identification of slip planes in organic crystals based on attachment energy calculation. J Pharm Sci. 2008 Aug; 97(8):3456-61.
    View in: PubMed
    Score: 0.293
  5. Solid-state properties and crystallization behavior of PHA-739521 polymorphs. Int J Pharm. 2006 Aug 17; 319(1-2):114-20.
    View in: PubMed
    Score: 0.250
  6. Simultaneously improving tabletability and solubility of diclofenac by cocrystallization with picolinamide. Int J Pharm. 2025 Feb 10; 670:125172.
    View in: PubMed
    Score: 0.229
  7. Efficient determination of critical water activity and classification of hydrate-anhydrate stability relationship. J Pharm Sci. 2025 Jan; 114(1):127-135.
    View in: PubMed
    Score: 0.221
  8. Understanding the roles of compaction pressure and crystal hardness on powder tabletability through bonding area - Bonding strength interplay. Int J Pharm. 2024 Jun 25; 659:124253.
    View in: PubMed
    Score: 0.219
  9. Miscibility of amorphous solid dispersions: A rheological and solid-state NMR spectroscopy study. J Pharm Sci. 2025 Jan; 114(1):119-126.
    View in: PubMed
    Score: 0.219
  10. Delaying the first nucleation event of amorphous solid dispersions above the polymer overlap concentration (c*): PVP and PVPVA in posaconazole. J Pharm Sci. 2025 Jan; 114(1):98-104.
    View in: PubMed
    Score: 0.218
  11. Crystallization inhibition in molecular liquids by polymers above the overlap concentration (c*): Delay of the first nucleation event. J Pharm Sci. 2025 Jan; 114(1):82-88.
    View in: PubMed
    Score: 0.215
  12. Modulating Pharmaceutical Properties of Berberine Chloride through Cocrystallization with Benzendiol Isomers. Pharm Res. 2023 Dec; 40(12):2791-2800.
    View in: PubMed
    Score: 0.205
  13. Mechanisms of Crystal Plasticization by Lattice Water. Pharm Res. 2022 Dec; 39(12):3113-3122.
    View in: PubMed
    Score: 0.188
  14. Complexation with aromatic carboxylic acids expands the solid-state landscape of berberine. Int J Pharm. 2022 Apr 05; 617:121587.
    View in: PubMed
    Score: 0.187
  15. Simultaneous improvement of physical stability, dissolution, bioavailability, and antithrombus efficacy of Aspirin and Ligustrazine through cocrystallization. Int J Pharm. 2022 Mar 25; 616:121541.
    View in: PubMed
    Score: 0.187
  16. The efficient development of a sildenafil orally disintegrating tablet using a material sparing and expedited approach. Int J Pharm. 2020 Nov 15; 589:119816.
    View in: PubMed
    Score: 0.169
  17. Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach. Pharm Res. 2020 Jul 23; 37(8):153.
    View in: PubMed
    Score: 0.168
  18. Molecular Origin of the Distinct Tabletability of Loratadine and Desloratadine: Role of the Bonding Area - Bonding Strength Interplay. Pharm Res. 2020 Jun 28; 37(7):133.
    View in: PubMed
    Score: 0.167
  19. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies. Mol Pharm. 2020 07 06; 17(7):2232-2244.
    View in: PubMed
    Score: 0.167
  20. Reduction of Punch-Sticking Propensity of Celecoxib by Spherical Crystallization via Polymer Assisted Quasi-Emulsion Solvent Diffusion. Mol Pharm. 2020 04 06; 17(4):1387-1396.
    View in: PubMed
    Score: 0.164
  21. Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods. Int J Pharm. 2020 Jan 25; 574:118914.
    View in: PubMed
    Score: 0.161
  22. Relationship between hydrate stability and accuracy of true density measured by helium pycnometry. Int J Pharm. 2019 Aug 15; 567:118444.
    View in: PubMed
    Score: 0.156
  23. Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer. Pharm Res. 2019 Apr 23; 36(6):90.
    View in: PubMed
    Score: 0.154
  24. Computational Techniques for Predicting Mechanical Properties of Organic Crystals: A Systematic Evaluation. Mol Pharm. 2019 04 01; 16(4):1732-1741.
    View in: PubMed
    Score: 0.153
  25. Direct Compression Tablet Containing 99% Active Ingredient-A Tale of Spherical Crystallization. J Pharm Sci. 2019 04; 108(4):1396-1400.
    View in: PubMed
    Score: 0.150
  26. Improving solid-state properties of berberine chloride through forming a salt cocrystal with citric acid. Int J Pharm. 2019 Jan 10; 554:14-20.
    View in: PubMed
    Score: 0.149
  27. Relating the tableting behavior of piroxicam polytypes to their crystal structures using energy-vector models. Int J Pharm. 2018 May 30; 543(1-2):46-51.
    View in: PubMed
    Score: 0.143
  28. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer. Pharm Res. 2017 12 29; 35(1):4.
    View in: PubMed
    Score: 0.141
  29. Mechanical Properties and Tableting Behavior of Amorphous Solid Dispersions. J Pharm Sci. 2017 01; 106(1):217-223.
    View in: PubMed
    Score: 0.130
  30. Enabling the Tablet Product Development of 5-Fluorocytosine by Conjugate Acid Base Cocrystals. J Pharm Sci. 2016 06; 105(6):1960-1966.
    View in: PubMed
    Score: 0.126
  31. The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance. Drug Dev Ind Pharm. 2016; 42(6):969-76.
    View in: PubMed
    Score: 0.121
  32. Effect of heating rate and kinetic model selection on activation energy of nonisothermal crystallization of amorphous felodipine. J Pharm Sci. 2014 Dec; 103(12):3950-3957.
    View in: PubMed
    Score: 0.113
  33. Enabling tablet product development of 5-fluorocytosine through integrated crystal and particle engineering. J Pharm Sci. 2014 Apr; 103(4):1126-32.
    View in: PubMed
    Score: 0.108
  34. Design, synthesis, and characterization of new 5-fluorocytosine salts. Mol Pharm. 2013 Jun 03; 10(6):2462-6.
    View in: PubMed
    Score: 0.102
  35. Cocrystallization for successful drug delivery. Expert Opin Drug Deliv. 2013 Feb; 10(2):201-13.
    View in: PubMed
    Score: 0.099
  36. Preparation and characterization of surface-engineered coarse microcrystalline cellulose through dry coating with silica nanoparticles. J Pharm Sci. 2012 Nov; 101(11):4258-66.
    View in: PubMed
    Score: 0.097
  37. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide. Pharm Res. 2012 Jul; 29(7):1854-65.
    View in: PubMed
    Score: 0.094
  38. Overcoming poor tabletability of pharmaceutical crystals by surface modification. Pharm Res. 2011 Dec; 28(12):3248-55.
    View in: PubMed
    Score: 0.090
  39. Materials science tetrahedron--a useful tool for pharmaceutical research and development. J Pharm Sci. 2009 May; 98(5):1671-87.
    View in: PubMed
    Score: 0.077
  40. Influence of crystal structure on the tableting properties of n-alkyl 4-hydroxybenzoate esters (parabens). J Pharm Sci. 2007 Dec; 96(12):3324-33.
    View in: PubMed
    Score: 0.070
  41. Thermal expansion of organic crystals and precision of calculated crystal density: a survey of Cambridge Crystal Database. J Pharm Sci. 2007 May; 96(5):1043-52.
    View in: PubMed
    Score: 0.067
  42. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example. Int J Pharm. 2006 Dec 01; 326(1-2):94-9.
    View in: PubMed
    Score: 0.064
  43. Improved tableting properties of p-hydroxybenzoic acid by water of crystallization: a molecular insight. Pharm Res. 2004 Feb; 21(2):382-6.
    View in: PubMed
    Score: 0.054
  44. Development of direct compression Acetazolamide tablet with improved bioavailability in healthy human volunteers enabled by cocrystallization with p-Aminobenzoic acid. Int J Pharm. 2024 Mar 05; 652:123793.
    View in: PubMed
    Score: 0.053
  45. A Rheological Approach for Predicting Physical Stability of Amorphous Solid Dispersions. J Pharm Sci. 2023 01; 112(1):204-212.
    View in: PubMed
    Score: 0.049
  46. Molecular Interpretation of the Compaction Performance and Mechanical Properties of Caffeine Cocrystals: A Polymorphic Study. Mol Pharm. 2020 01 06; 17(1):21-31.
    View in: PubMed
    Score: 0.040
  47. Effects of Water on Powder Flowability of Diverse Powders Assessed by Complimentary Techniques. J Pharm Sci. 2019 08; 108(8):2613-2620.
    View in: PubMed
    Score: 0.038
  48. Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin. Mol Pharm. 2019 03 04; 16(3):1305-1311.
    View in: PubMed
    Score: 0.038
  49. Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin. Eur J Pharm Sci. 2017 Jun 15; 104:255-261.
    View in: PubMed
    Score: 0.033
  50. Resveratrol cocrystals with enhanced solubility and tabletability. Int J Pharm. 2016 Jul 25; 509(1-2):391-399.
    View in: PubMed
    Score: 0.032
  51. Probing interfaces between pharmaceutical crystals and polymers by neutron reflectometry. Mol Pharm. 2012 Jul 02; 9(7):1953-61.
    View in: PubMed
    Score: 0.024
  52. A study of sulfamerazine single crystals using atomic force microscopy, transmission light microscopy, and Raman spectroscopy. J Pharm Sci. 2005 Sep; 94(9):1881-92.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.